top of page
    • Dec 21, 2023

Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis

Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides, and also as a biocatalyst for other RNA and DNA based products. Afterwards, we take a tour of the company's labs.



Comments

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE

bottom of page